The death of storied general and statesman Colin Powell from complications related to COVID-19 should not lead to any concerns about the efficacy of the coronavirus vaccines, according to experts and government officials.
The fact remains that unvaccinated people are 11 times more likely to die than those who have been vaccinated against COVID-19.
Please don’t let the death of an American icon become fodder for anti-vax forces that are putting untold millions in danger,” wrote Department of Health and Human Services adviser Ian Sams on Twitter. “Vaccines work. They prevent bad outcomes. They (like all vaccines) are not 100%, especially among older people with underlying/complicating health issues.”
Powell, who served as secretary of state during the George W. Bush administration and as chairman of the Joint Chiefs of Staff before that, died Monday at age 84.
Crucially, Powell suffered from a blood cancer known as multiple myeloma — precisely the kind of “immunocompromised” condition experts have said from the start could lead to lower vaccine efficacy. In fact, the vaccines seemed to work especially poorly in patients afflicted with that type of cancer, even after a booster shot. (Powell also suffered from Parkinson’s disease, a neurodegenerative condition.)
The fact remains that unvaccinated people are 11 times more likely to die than those who have been vaccinated against COVID-19.
Please don’t let the death of an American icon become fodder for anti-vax forces that are putting untold millions in danger,” wrote Department of Health and Human Services adviser Ian Sams on Twitter. “Vaccines work. They prevent bad outcomes. They (like all vaccines) are not 100%, especially among older people with underlying/complicating health issues.”
Powell, who served as secretary of state during the George W. Bush administration and as chairman of the Joint Chiefs of Staff before that, died Monday at age 84.
Crucially, Powell suffered from a blood cancer known as multiple myeloma — precisely the kind of “immunocompromised” condition experts have said from the start could lead to lower vaccine efficacy. In fact, the vaccines seemed to work especially poorly in patients afflicted with that type of cancer, even after a booster shot. (Powell also suffered from Parkinson’s disease, a neurodegenerative condition.)
